General Announcement for PLC
13/11/2017PROPOSED SUBSCRIPTION OF 2,100,000 NEW ORDINARY SHARES IN CYPRESS MEDIC SDN BHD REPRESENTING 51.03% OF THE ENLARGED SHARE CAPITAL OF CYPRESS MEDIC SDN BHD FOR A CASH CONSIDERATION OF RM1,722,000 ("PROPOSED SUBSCRIPTION")
BCM ALLIANCE BERHAD |
Type | Reply to Query |
Reply to Bursa Malaysia's Query Letter - Reference ID | IQL-10112017-00001 |
Subject | PROPOSED SUBSCRIPTION OF 2,100,000 NEW ORDINARY SHARES IN CYPRESS MEDIC SDN BHD REPRESENTING 51.03% OF THE ENLARGED SHARE CAPITAL OF CYPRESS MEDIC SDN BHD FOR A CASH CONSIDERATION OF RM1,722,000 ("PROPOSED SUBSCRIPTION") |
Description | BCM ALLIANCE BERHAD (BCM or the COMPANY) PROPOSED SUBSCRIPTION OF 2,100,000 NEW ORDINARY SHARES IN CYPRESS MEDIC SDN BHD REPRESENTING 51.03% OF THE ENLARGED SHARE CAPITAL OF CYPRESS MEDIC SDN BHD FOR A CASH CONSIDERATION OF RM1,722,000 ("PROPOSED SUBSCRIPTION") |
Query Letter Contents | We refer to your Company’s announcement dated 9 November 2017, in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- 1. The original cost of investment by the vendors in Cypress Medic Sdn Bhd ("Cypress") and the date of such investment. 2. Whether the Interested Directors have abstained and will abstain from all deliberations at Board meetings in respect of the Proposed Subscription. Please furnish Bursa Securities with your reply within one (1) market day from the date hereof. Yours faithfully,
TAN YEW ENG TYE/NZ Cc : Market Surveillance Dept. , Securities Commission (via fax) |
(The terms used herein, unless the context otherwise stated, bear the same meaning as those defined in the Company’s announcement made on 9 November 2017 in relation to the Proposed Subscription) Reference is made to the Company’s announcement made on 9 November 2017. The Board of Directors of BCM wishes to provide the following additional information: 1. The original cost of investment by the vendors in Cypress Medic Sdn Bhd (“Cypress”) and the date of such investment Kindly refer to Appendix I attached for further information. 2. Whether the Interested Directors have abstained and will abstain from all deliberation at Board meetings in respect of the Proposed Subscription. The Interested Directors have abstained and will continue to abstain from deliberating and voting on the Proposed Subscription at the relevant Board meeting. This announcement is dated 13 November 2017. |
Please refer attachment below.
Attachments
Appendix I.pdf
|
Announcement Info
Company Name | BCM ALLIANCE BERHAD |
Stock Name | BCMALL |
Date Announced | 13 Nov 2017 |
Category | General Announcement for PLC |
Reference Number | GA1-13112017-00057 |